Google’s Biotech Investment In Brin’s Wife’s Company, 23andMe
Raising some eyebrows this morning is Google’s investment in a biotech firm called 23andMe, which states as its mission to: “help you make sense of your own genetic information . . . [and] put your genome into the larger context of human commonality and diversity.” Anne Wojcicki, Google cofounder Sergey Brin’s new wife, is a […]
Raising some eyebrows this morning is Google’s investment in a biotech firm called 23andMe, which states as its mission to: “help you make sense of your own genetic information . . . [and] put your genome into the larger context of human commonality and diversity.”
Anne Wojcicki, Google cofounder Sergey Brin’s new wife, is a cofounder of 23andMe. Esther Dyson is a board member. According to regulatory filings, Google took a minority stake in the company for $3.9 million. Here are some more reports from SF Gate and the NY Times.
Joining Google in the series A investment round were New Enterprise Associates, MDV-Mohr Davidow Ventures and Genentech.
Opinions expressed in this article are those of the guest author and not necessarily Search Engine Land. Staff authors are listed here.
Related stories
New on Search Engine Land
About the author
